Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements

v3.10.0.1
Restatement of Previously Issued Financial Statements
3 Months Ended
Mar. 31, 2017
Accounting Changes and Error Corrections [Abstract]  
Restatement of Previously Issued Financial Statements

Note 2 – Restatement of Previously Issued Financial Statements

 

The Company determined that when calculating its income tax provision related to the gain on sale of discontinued operations, it incorrectly utilized available net operating losses without considering the statutory limitations imposed by the state of Pennsylvania, and that it incorrectly allocated the amount of income tax benefit resulting from the reversal of certain valuation allowances to continuing operations, which resulted in an overstatement of income the tax benefit from continuing operations and an understatement of the gain on sale of discontinued operations, which is presented net of taxes. In the process of this determination, the Company determined that such information existed at March 31, 2017 which affected the income tax benefit/ provision from continuing and discontinued operations reported in the three months ended March 31, 2017. The Company concluded that the impact of applying corrections for these errors and misstatements on the consolidated financial statements as of and for the three months ended March 31, 2017 is material. As a result, the Company is restating its consolidated financial statements as of and for the three months ended March 31, 2017. See below for a reconciliation of the previously reported amounts to the restated amounts.

 

The table below sets forth the condensed consolidated balance sheet, including the balances as originally reported, adjustments and the as restated balances (in thousands):

 

    As of March 31, 2017  
    As originally reported     Adjustments     As restated  
                   
Income taxes payable   $ 1,340     $ 751     $ 2,091  
Total current liabilities     6,873       751       7,624  
                         
Retained earnings     24,952       (751 )     24,201  
Total stockholders' equity     50,670       (751 )     49,919  
Total liabilities and stockholders' equity   $ 57,543     $ -     $ 57,543  

 

The table below sets for the condensed consolidated statements of operations, including the balances as originally reported, adjustments, and the as restated amounts (in thousands):

 

    For the three months ended March 31, 2017  
    As originally reported     Adjustments     As restated  
                   
Income tax benefit from continuing operations   $ 18,123     $ (17,670 )   $ 453  
Income (loss) from continuing operations     16,925       (17,670 )     (745 )
                         
Gain on sale of discontinued operations, net of taxes     26,349       16,919       43,268  
Income from discontinued operations     27,714       16,919       44,633  
Net income     44,639       (751 )     43,888  
                         
Basic earnings (loss) per share:                        
Income (loss) from continuing operations   $ 0.99     $ (1.03 )   $ (0.04 )
Income from discontinued operations     1.62       0.99       2.61  
Net income   $ 2.61     $ (0.04 )   $ 2.57  
                         
Diluted earnings (loss) per share:                        
Income (loss) from continuing operations   $ 0.95     $ (0.99 )   $ (0.04 )
Income from discontinued operations     1.56       0.95       2.51  
Net income   $ 2.51     $ (0.04 )   $ 2.47  

  

The table below sets forth the condensed consolidated statements of cash flows from operating activities, including the balances as originally reported, adjustments and the as restated balances (in thousands):

 

    For the three months ended March 31, 2017  
    As originally reported     Adjustments     As restated  
                   
Net income   $ 44,639     $ (751 )   $ 43,888  
Gain on sale of assets, net of taxes     (26,349 )     (16,919 )     (43,268 )
Change in valuation allowance, income tax benefit     (18,123 )     17,670       (453 )
Net cash used in operating activities   $ 3,007     $ -     $ 3,007  

 

The restatement had no impact on cash flows from investing activities or financing activities or net increase in cash.